Operating Margin of Arch Therapeutics, Inc. from 31 Mar 2021 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arch Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Mar 2021 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Operating Margin for the quarter ending 30 Jun 2024 was -3187%, a 77% increase year-over-year.
  • Arch Therapeutics, Inc. annual Operating Margin for 2023 was -6662%, a 82% increase from 2022.
  • Arch Therapeutics, Inc. annual Operating Margin for 2022 was -36473%, a 34% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Arch Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -3187% +10465% +77% 01 Apr 2024 30 Jun 2024
Q1 2024 -3612% +13139% +78% 01 Jan 2024 31 Mar 2024
Q4 2023 -4564% +27235% +86% 01 Oct 2023 31 Dec 2023
Q3 2023 -6662% +29812% +82% 01 Jul 2023 30 Sep 2023
Q2 2023 -13652% +24634% +64% 01 Apr 2023 30 Jun 2023
Q1 2023 -16751% +54099% +76% 01 Jan 2023 31 Mar 2023
Q4 2022 -31798% +9116% +22% 01 Oct 2022 31 Dec 2022
Q3 2022 -36473% +18668% +34% 01 Jul 2022 30 Sep 2022
Q2 2022 -38286% +21785% +36% 01 Apr 2022 30 Jun 2022
Q1 2022 -70850% -15083% -27% 01 Jan 2022 31 Mar 2022
Q4 2021 -40915% 01 Oct 2021 31 Dec 2021
Q3 2021 -55142% 01 Jul 2021 30 Sep 2021
Q2 2021 -60071% 01 Apr 2021 30 Jun 2021
Q1 2021 -55766% 01 Jan 2021 31 Mar 2021

Arch Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -6662% +29812% +82% 01 Oct 2022 30 Sep 2023
2022 -36473% +18668% +34% 01 Oct 2021 30 Sep 2022
2021 -55142% 01 Oct 2020 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.